CSF2 and neoplasm: The DCs are created via isolation of monocytes from patient sera, then stimulation with IL-4, GM-CSF, then TNF-α, and finally by adding the peptides (derived from autologous tumor lysate or synthetically produced) to the DCs in a pulsed fashion to improve antigen presentation [136].